AP2015008325A0 - Tri(hetero)aryl pyrazoles and use thereof - Google Patents

Tri(hetero)aryl pyrazoles and use thereof

Info

Publication number
AP2015008325A0
AP2015008325A0 AP2015008325A AP2015008325A AP2015008325A0 AP 2015008325 A0 AP2015008325 A0 AP 2015008325A0 AP 2015008325 A AP2015008325 A AP 2015008325A AP 2015008325 A AP2015008325 A AP 2015008325A AP 2015008325 A0 AP2015008325 A0 AP 2015008325A0
Authority
AP
ARIPO
Prior art keywords
hetero
tri
aryl pyrazoles
pyrazoles
aryl
Prior art date
Application number
AP2015008325A
Other languages
English (en)
Inventor
Steffen Wildum
Astrid Wendt
Burkhard Klenke
Original Assignee
Aicuris Gmbh & Co Kg
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=48986151&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=AP2015008325(A0) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Aicuris Gmbh & Co Kg filed Critical Aicuris Gmbh & Co Kg
Publication of AP2015008325A0 publication Critical patent/AP2015008325A0/xx

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4427Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
    • A61K31/4439Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47Quinolines; Isoquinolines
    • A61K31/4738Quinolines; Isoquinolines ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/4745Quinolines; Isoquinolines ortho- or peri-condensed with heterocyclic ring systems condensed with ring systems having nitrogen as a ring hetero atom, e.g. phenantrolines
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • A61P31/14Antivirals for RNA viruses
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • A61P31/14Antivirals for RNA viruses
    • A61P31/18Antivirals for RNA viruses for HIV
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D403/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/04Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04Ortho-condensed systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D487/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Virology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Molecular Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • AIDS & HIV (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Plural Heterocyclic Compounds (AREA)
AP2015008325A 2012-08-17 2013-08-16 Tri(hetero)aryl pyrazoles and use thereof AP2015008325A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE102012016908.6A DE102012016908A1 (de) 2012-08-17 2012-08-17 Tris-(Hetero)Aryl-Pyrazole und ihre Verwendung
PCT/EP2013/067201 WO2014027112A1 (de) 2012-08-17 2013-08-16 Tris-(hetero)aryl-pyrazole und ihre verwendung

Publications (1)

Publication Number Publication Date
AP2015008325A0 true AP2015008325A0 (en) 2015-03-31

Family

ID=48986151

Family Applications (1)

Application Number Title Priority Date Filing Date
AP2015008325A AP2015008325A0 (en) 2012-08-17 2013-08-16 Tri(hetero)aryl pyrazoles and use thereof

Country Status (27)

Country Link
US (1) US9249148B2 (enExample)
EP (1) EP2885300A1 (enExample)
JP (1) JP2015524835A (enExample)
KR (1) KR20150042841A (enExample)
CN (1) CN104684913B (enExample)
AP (1) AP2015008325A0 (enExample)
AR (1) AR092145A1 (enExample)
AU (1) AU2013303993A1 (enExample)
BR (1) BR112015003115A2 (enExample)
CA (1) CA2881997A1 (enExample)
CL (1) CL2015000362A1 (enExample)
CU (1) CU20150015A7 (enExample)
DE (1) DE102012016908A1 (enExample)
EA (1) EA201500232A1 (enExample)
HK (1) HK1212327A1 (enExample)
IL (1) IL237298A0 (enExample)
MA (1) MA37928A1 (enExample)
MX (1) MX2015002046A (enExample)
NZ (1) NZ704727A (enExample)
PE (1) PE20150869A1 (enExample)
PH (1) PH12015500322B1 (enExample)
SG (1) SG11201501183VA (enExample)
TN (1) TN2015000045A1 (enExample)
TW (1) TW201412720A (enExample)
UA (1) UA112488C2 (enExample)
WO (1) WO2014027112A1 (enExample)
ZA (1) ZA201501078B (enExample)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE102012016908A1 (de) 2012-08-17 2014-02-20 Aicuris Gmbh & Co. Kg Tris-(Hetero)Aryl-Pyrazole und ihre Verwendung
WO2015121413A1 (en) * 2014-02-14 2015-08-20 Aicuris Gmbh & Co. Kg New active pharmaceutical ingredient combinations with compounds based on tri(hetero)aryl pyrazoles
EP3263567A1 (en) * 2016-07-01 2018-01-03 AiCuris Anti-infective Cures GmbH Carboxamide-substituted pyrazoles and tri(hetero)aryl-pyrazoles for use in methods of treating and / or preventing cardiovascular diseases and / or comorbidities thereof
SG11202009179TA (en) * 2018-04-04 2020-10-29 Japan Tobacco Inc Pyrazole compounds substituted with heteroaryl and pharmaceutical use thereof

Family Cites Families (38)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PH27357A (en) 1989-09-22 1993-06-21 Fujisawa Pharmaceutical Co Pyrazole derivatives and pharmaceutical compositions comprising the same
IL104311A (en) 1992-02-05 1997-07-13 Fujisawa Pharmaceutical Co Pyrazole derivatives, processes for the preparation thereof and pharmaceutical compositions containing the same
FR2692575B1 (fr) 1992-06-23 1995-06-30 Sanofi Elf Nouveaux derives du pyrazole, procede pour leur preparation et compositions pharmaceutiques les contenant.
US6277847B1 (en) 1999-04-02 2001-08-21 Fmc Corporation Herbicidal isoindolinonyl-and 3,4-dihydroisoquinolonyl-substituted heterocycles
EP1451160B1 (en) 2001-11-01 2010-01-13 Icagen, Inc. Pyrazole-amides for use in the treatment of pain
US6649638B1 (en) * 2002-08-14 2003-11-18 Ppd Discovery, Inc. Prenylation inhibitors and methods of their synthesis and use
MXPA05005742A (es) 2002-12-02 2005-08-16 Astellas Pharma Inc Derivados de pirazol utiles como inhibidores de cox-i.
WO2004069824A1 (ja) 2003-02-07 2004-08-19 Daiichi Pharmaceutical Co., Ltd. ピラゾール誘導体
JP4208925B2 (ja) 2004-02-20 2009-01-14 アストラゼネカ アクチボラグ 治療薬
WO2005092856A1 (en) 2004-03-26 2005-10-06 F. Hoffmann-La Roche Ag Tetrahydrocarbazoles and derivatives
AU2005258397A1 (en) 2004-07-01 2006-01-12 Daiichi Pharmaceutical Co., Ltd. Pyrazole derivatives
GB0417910D0 (en) 2004-08-11 2004-09-15 Novartis Ag Organic compounds
DE102004054666A1 (de) 2004-11-12 2006-05-18 Bayer Cropscience Gmbh Substituierte Pyrazol-3-carboxamide, Verfahren zur Herstellung und Verwendung als Herbizide und Pflanzenwachstumsregulatoren
EP1910307A1 (en) 2005-06-27 2008-04-16 Exelixis, Inc. Pyrazole based lxr modulators
ES2326723B1 (es) 2005-07-15 2010-05-11 Laboratorios Del Dr. Esteve, S.A. Uso de compuestos de pirazol sustituidos y combinaciones de los mismos para el tratamiento del sindrome metabolico.
EP1743637A1 (en) 2005-07-15 2007-01-17 Laboratorios Del Dr. Esteve, S.A. Use of substituted pyrazole compounds and combinations thereof for the treatment of the metabolic syndrome
GB0516661D0 (en) 2005-08-13 2005-09-21 Astrazeneca Ab Therapeutic agents
ES2632940T3 (es) 2005-09-13 2017-09-18 Janssen Pharmaceutica Nv Derivados de tiazol sustituidos con 2-anilin-4-arilo
US20090143413A1 (en) 2005-11-29 2009-06-04 Adams Alan D Thiazole Derivatives as CXCR3 Receptor Modulators
EP2044053A2 (en) 2005-12-01 2009-04-08 Bayer Healthcare, LLC Urea compounds useful in the treatment of cancer
WO2008017932A2 (en) 2006-08-09 2008-02-14 Pfizer Products Inc. Heterocycles useful as inhibitors of carbonic anhydrase
US8188113B2 (en) 2006-09-14 2012-05-29 Deciphera Pharmaceuticals, Inc. Dihydropyridopyrimidinyl, dihydronaphthyidinyl and related compounds useful as kinase inhibitors for the treatment of proliferative diseases
GB0625196D0 (en) 2006-12-18 2007-01-24 7Tm Pharma As Modulators of cannabinoid receptor
JP4994295B2 (ja) * 2007-04-20 2012-08-08 田辺三菱製薬株式会社 医薬組成物
JP5498392B2 (ja) 2007-11-30 2014-05-21 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング 1,5−ジヒドロ−ピラゾロ[3,4−d]ピリミジン−4−オン誘導体及びcns障害の治療のためのpde9aモジュレーターとしてのそれらの使用
AR069650A1 (es) 2007-12-14 2010-02-10 Actelion Pharmaceuticals Ltd Derivados de aminopirazol como agonistas no peptidicos del receptor alx humano
WO2009103626A1 (en) 2008-02-18 2009-08-27 F. Hoffmann-La Roche Ag 4, 5-dihydro-oxazol-2-yl amine derivatives
DE102008015033A1 (de) 2008-03-17 2009-09-24 Aicuris Gmbh & Co. Kg Substituierte (Pyrazolyl-carbonyl)imidazolidinone und ihre Verwendung
DE102008015032A1 (de) * 2008-03-17 2009-09-24 Aicuris Gmbh & Co. Kg Substituierte Pyrazolamide und ihre Verwendung
TW201041888A (en) * 2009-05-06 2010-12-01 Plexxikon Inc Compounds and methods for kinase modulation, and indications therefor
TW201100441A (en) 2009-06-01 2011-01-01 Osi Pharm Inc Amino pyrimidine anticancer compounds
KR101710197B1 (ko) 2009-09-17 2017-02-24 얀센 파마슈티카 엔.브이. 치환된 n-페닐-1-(4-피리디닐)-1h-피라졸-3-아민
JP5735526B2 (ja) 2009-11-13 2015-06-17 メルク セローノ ソシエテ アノニム 三環式ピラゾールアミン誘導体
WO2012009009A2 (en) 2010-07-14 2012-01-19 Addex Pharma S.A. Novel 2-amino-4-pyrazolyl-thiazole derivatives and their use as allosteric modulators of metabotropic glutamate receptors
US20130203756A1 (en) 2010-10-29 2013-08-08 Jamie L. Bunda Isoindoline pde10 inhibitors
US9938269B2 (en) 2011-06-30 2018-04-10 Abbvie Inc. Inhibitor compounds of phosphodiesterase type 10A
DE102012016908A1 (de) 2012-08-17 2014-02-20 Aicuris Gmbh & Co. Kg Tris-(Hetero)Aryl-Pyrazole und ihre Verwendung
WO2015121413A1 (en) 2014-02-14 2015-08-20 Aicuris Gmbh & Co. Kg New active pharmaceutical ingredient combinations with compounds based on tri(hetero)aryl pyrazoles

Also Published As

Publication number Publication date
MA37928A1 (fr) 2017-11-30
IL237298A0 (en) 2015-04-30
CN104684913B (zh) 2016-11-23
EA201500232A1 (ru) 2015-07-30
JP2015524835A (ja) 2015-08-27
TW201412720A (zh) 2014-04-01
AU2013303993A1 (en) 2015-03-12
UA112488C2 (uk) 2016-09-12
CA2881997A1 (en) 2014-02-20
CL2015000362A1 (es) 2015-07-10
AR092145A1 (es) 2015-03-25
BR112015003115A2 (pt) 2017-07-04
PH12015500322A1 (en) 2015-03-30
PE20150869A1 (es) 2015-05-27
NZ704727A (en) 2016-07-29
MX2015002046A (es) 2015-06-05
CN104684913A (zh) 2015-06-03
DE102012016908A1 (de) 2014-02-20
US20150203500A1 (en) 2015-07-23
EP2885300A1 (de) 2015-06-24
HK1212327A1 (en) 2016-06-10
PH12015500322B1 (en) 2019-03-25
ZA201501078B (en) 2017-11-29
US9249148B2 (en) 2016-02-02
WO2014027112A1 (de) 2014-02-20
TN2015000045A1 (en) 2016-06-29
KR20150042841A (ko) 2015-04-21
SG11201501183VA (en) 2015-05-28
CU20150015A7 (es) 2015-11-27

Similar Documents

Publication Publication Date Title
IL233220A0 (en) System and apparatus for producing a spray
GB2508520B (en) Methods and devices for compound delivery
IL233466A0 (en) A device for creating an elongated spray and a system
GB2509400B (en) Rigid-stem lead-in-method and system
PL2848254T3 (pl) Pochodne pirazolu i ich zastosowanie w celach medycznych
PL3466282T3 (pl) Urządzenia generujące aerozol
IL233438A0 (en) Polygonal system and device for creating a spray
EP2828258A4 (en) NOVEL PYRIDOPYRIMIDINE DERIVATIVES AND THEIR USE
PL2904124T3 (pl) Urządzenie manipulacyjne
GB201714556D0 (en) Partition system and accessories for use therewith
ZA201405392B (en) Substituted phenylimidazopyrazoles and use thereof
EP2826502A4 (en) BLOOD FLOW PATH CONNECTION DEVICE AND BLOOD POCKET SYSTEM
IL239372B (en) Triazolone compounds and their uses
IL233625A (en) Cf3o-containing aminoctones and their use to make cf3o-containing pyrazoles
EP2847474A4 (en) CROCHET SYSTEM AND USE THEREOF
SG11201501183VA (en) Tri(hetero)aryl pyrazoles and use thereof
SG11201502097WA (en) Microwave amplifier device
GB2516390B (en) Implanted-into-eye device and updating system of same
PL2884837T3 (pl) Usprawnienia w urządzeniach do obsługi zwierząt
PL2666353T3 (pl) Urządzenie do ręcznej zrywki pni
EP2869700A4 (en) ORNIDAZOLE AND RELATED COMPOUNDS FOR USE AS HERBICIDES
GB2502895B (en) Trouser Braces and Adaptor
GB201209901D0 (en) Communication device and methods
GB201200268D0 (en) Accessories for portable devices
GB201222541D0 (en) Kiddibidet and pottibidet